
Results
16
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
16 companies
Laurus Labs
Market Cap: ₹999.7b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,851.70
7D
1.2%
1Y
115.4%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$65.7b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$70.25
7D
26.5%
1Y
186.0%
Anthem Biosciences
Market Cap: ₹492.7b
Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.
ANTHEM
₹874.90
7D
6.0%
1Y
6.1%
Emcure Pharmaceuticals
Market Cap: ₹381.0b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹2,009.60
7D
3.8%
1Y
38.1%
Sai Life Sciences
Market Cap: ₹307.8b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹1,451.20
7D
2.7%
1Y
63.5%
Neuland Laboratories
Market Cap: ₹297.9b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹23,222.15
7D
8.0%
1Y
75.1%
Rubicon Research
Market Cap: ₹268.3b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹1,620.70
7D
5.7%
1Y
n/a
Acutaas Chemicals
Market Cap: ₹254.7b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,110.60
7D
-4.6%
1Y
139.3%
Granules India
Market Cap: ₹212.5b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.
532482
₹857.45
7D
2.3%
1Y
86.8%
Jinyu Bio-technology
Market Cap: CN¥14.9b
Engages in the research and development, production, and sale of veterinary biological products in China and internationally.
600201
CN¥13.64
7D
4.2%
1Y
62.0%
Aether Industries
Market Cap: ₹209.7b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹1,580.10
7D
-0.3%
1Y
113.1%
Inner Mongolia Furui Medical Science
Market Cap: CN¥12.2b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥46.38
7D
7.7%
1Y
-4.5%
Shilpa Medicare
Market Cap: ₹157.9b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.
530549
₹807.40
7D
9.1%
1Y
78.1%
Viyash Scientific
Market Cap: ₹116.3b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹266.45
7D
-2.4%
1Y
51.9%
Strides Pharma Science
Market Cap: ₹91.2b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹989.20
7D
-0.8%
1Y
10.5%
Sakar Healthcare
Market Cap: ₹20.4b
Research, develops, manufactures, and sells pharmaceutical products in India.
SAKAR
₹918.30
7D
-0.2%
1Y
182.0%